Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G European acquisition

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble finalizes the acquisition of Sanofi-Aventis' global portfolio of oral care products, the company announces Sept. 1. The deal adds two leading European lines, Fluocaril and Parogencyl, to P&G's existing oral care portfolio, which includes the Crest and Fixodent brands. The purchase "not only consolidates our business in major European oral care markets, like France and Iberia, it also provides us with the perfect opportunity to build P&G's presence in the pharmacy channel," the firm stated. Sanofi-Aventis will continue manufacturing Fluocaril and Parogencyl for at least five years...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts